Rubicon Organics Obtains Key Certification for International Export
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) has achieved a significant milestone by receiving the CUMCS Equivalency IMC-G.A.P. certification for its Delta Facility. This certification, granted by Control Union (CU), enables the company to export cannabis products to Israel, Europe, and Australia.
The certification confirms compliance with multiple international standards, including WHO guidelines on Good Agricultural Practices, European Medicines Agency's guidelines, Dutch Office of Medicinal Cannabis' Guidelines, and GLOBALG.A.P.'s IFA 4.0. This certification validates Rubicon's ability to meet strict international standards for quality and consistency in cannabis cultivation, harvest, and primary processing.
The company plans to initiate exports in 2025, targeting facilities with Good Manufacturing Practices (GMP) certification in these regions. CEO Margaret Brodie noted strong demand for Rubicon's premium and organic cannabis in international medical markets.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) ha raggiunto un traguardo significativo ricevendo la certificazione CUMCS Equivalency IMC-G.A.P. per il suo stabilimento di Delta. Questa certificazione, concessa da Control Union (CU), consente all'azienda di esportare prodotti a base di cannabis in Israele, Europa e Australia.
La certificazione conferma la conformità a molteplici standard internazionali, comprese le linee guida dell'OMS sulle Buone Pratiche Agricole, le linee guida dell'Agenzia Europea dei Medicinali, le linee guida dell'Ufficio Olandese della Cannabis Medicinale e l'IFA 4.0 di GLOBALG.A.P. Questa certificazione valida la capacità di Rubicon di soddisfare rigorosi standard internazionali per la qualità e la coerenza nella coltivazione, nella raccolta e nella lavorazione primaria della cannabis.
L'azienda prevede di avviare le esportazioni nel 2025, mirando a strutture con certificazione di Buone Pratiche di Fabbricazione (GMP) in queste regioni. L'amministratore delegato Margaret Brodie ha osservato una forte domanda per la cannabis premium e biologica di Rubicon nei mercati medici internazionali.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) ha alcanzado un hito significativo al recibir la certificación CUMCS Equivalency IMC-G.A.P. para su instalación en Delta. Esta certificación, otorgada por Control Union (CU), permite a la empresa exportar productos de cannabis a Israel, Europa y Australia.
La certificación confirma el cumplimiento de múltiples estándares internacionales, incluidas las directrices de la OMS sobre Buenas Prácticas Agrícolas, las directrices de la Agencia Europea de Medicamentos, las directrices de la Oficina Holandesa de Cannabis Medicinal y la IFA 4.0 de GLOBALG.A.P. Esta certificación valida la capacidad de Rubicon para cumplir con estrictos estándares internacionales de calidad y consistencia en el cultivo, la cosecha y el procesamiento primario del cannabis.
La empresa planea iniciar las exportaciones en 2025, apuntando a instalaciones con certificación de Buenas Prácticas de Manufactura (GMP) en estas regiones. La CEO Margaret Brodie destacó la alta demanda de cannabis premium y orgánico de Rubicon en los mercados médicos internacionales.
루비콘 유기농 (TSXV: ROMJ) (OTCQX: ROMJF)가 델타 시설에 대한 CUMCS 동등성 IMC-G.A.P. 인증을 받아 중요한 이정표를 달성했습니다. 이 인증은 Control Union (CU)에서 부여한 것으로, 회사가 이스라엘, 유럽, 호주에 대마 제품을 수출할 수 있게 합니다.
이 인증은 WHO의 좋은 농업 관행에 관한 지침, 유럽 의약품청의 지침, 네덜란드 의약용 대마 사무소의 지침, GLOBALG.A.P.의 IFA 4.0을 포함한 여러 국제 표준에 대한 준수를 확인합니다. 이 인증은 루비콘이 대마의 재배, 수확 및 1차 가공에 있어 엄격한 국제 표준을 충족할 수 있는 능력을 유효화합니다.
회사는 2025년에 수출을 시작할 계획이며, 이러한 지역의 좋은 제조 관행(GMP) 인증을 보유한 시설을 목표로 하고 있습니다. CEO인 마가렛 브로디는 국제 의료 시장에서 루비콘의 프리미엄 및 유기농 대마에 대한 강한 수요가 있다고 언급했습니다.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) a atteint une étape importante en obtenant la certification CUMCS Equivalency IMC-G.A.P. pour son installation à Delta. Cette certification, délivrée par Control Union (CU), permet à l'entreprise d'exporter des produits à base de cannabis vers Israël, l'Europe et l'Australie.
La certification confirme la conformité à plusieurs normes internationales, y compris les directives de l'OMS sur les Bonnes Pratiques Agricoles, les lignes directrices de l'Agence Européenne des Médicaments, les directives du Bureau Néerlandais du Cannabis Médical et l'IFA 4.0 de GLOBALG.A.P. Cette certification valide la capacité de Rubicon à répondre à des normes internationales strictes en matière de qualité et de cohérence dans la culture, la récolte et le traitement primaire du cannabis.
L'entreprise prévoit de commencer les exportations en 2025, visant des installations disposant d'une certification de Bonnes Pratiques de Fabrication (GMP) dans ces régions. La PDG Margaret Brodie a noté une demande forte pour le cannabis biologique et premium de Rubicon sur les marchés médicaux internationaux.
Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) hat einen bedeutenden Meilenstein erreicht, indem es die CUMCS Equivalency IMC-G.A.P. Zertifizierung für seine Delta-Anlage erhalten hat. Diese Zertifizierung, die von Control Union (CU) vergeben wurde, ermöglicht es dem Unternehmen, Cannabisprodukte nach Israel, Europa und Australien zu exportieren.
Die Zertifizierung bestätigt die Einhaltung mehrerer internationaler Standards, einschließlich der WHO-Richtlinien für gute landwirtschaftliche Praktiken, der Richtlinien der Europäischen Arzneimittelagentur, der Richtlinien des niederländischen Büros für medizinisches Cannabis und der IFA 4.0 von GLOBALG.A.P. Diese Zertifizierung bestätigt die Fähigkeit von Rubicon, strenge internationale Standards für Qualität und Konsistenz im Anbau, der Ernte und der primären Verarbeitung von Cannabis zu erfüllen.
Das Unternehmen plant, 2025 mit den Exporten zu beginnen und richtet sich an Einrichtungen mit einer Zertifizierung für gute Herstellungspraxis (GMP) in diesen Regionen. CEO Margaret Brodie bemerkte eine starke Nachfrage nach Rubicons hochwertigen und biologischen Cannabis auf den internationalen medizinischen Märkten.
- Obtained IMC-G.A.P. certification enabling access to international medical cannabis markets
- Opens export opportunities to Israel, Europe, and Australia
- Positions company to meet existing international demand for premium organic cannabis
- Planned export initiation in 2025
- None.
- Granted IMC-G.A.P. Equivalency Certification by Control Union (“CU”)
- Milestone to export to Israel and EU-GMP facilities in Europe and Australia
VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that its Delta Facility has received its CUMCS Equivalency IMC-G.A.P. certification (the “Certification”), the leading certification standard for medical cannabis cultivation, harvest, and primary processing.
“There is tremendous demand for Rubicon Organic’s premium and organic cannabis from the international medical markets and we are ready to meet the rising demand for high-quality medical cannabis products with initial exports planned in 2025,” said Margaret Brodie, Chief Executive Officer.
Through the IMC-G.A.P. certification process, CU has declared that Rubicon Organics’ dried cannabis products are compliant in accordance with the World Health Organization’s (“WHO”) guidelines on Good Agricultural Practices (“GACP”) Medicinal Plants, the European Medicines Agency’s (“EMEA”) guideline on GACP for starting materials of herbal origin, Dutch Office of Medicinal Cannabis' Guidelines for cultivating cannabis for medicinal purposes, and GLOBALG.A.P.'s IFA 4.0 (FV), thus demonstrating equivalency to the Israeli Medical Cannabis Agency at the Ministry of Health (IMCA) Directive 151/2016 - IMC-GAP Certification.
Obtaining the Certification provides documented evidence that Rubicon Organics has met strict international standards for quality and consistency in the cultivation, harvest and primary processing of cannabis needed for export of cannabis inputs to certain jurisdictions, including Israel, Europe and Australia, for further processing into finished goods via a Good Manufacturing Practices (“GMP”) certified production facility.
ABOUT RUBICON ORGANICS INC.
Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare™ Organic, its premium brand 1964 Supply Co™, and its cannabis wellness brand Wildflower™ in addition to the Company’s mainstream brand Homestead Cannabis Supply™.
The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada.
ABOUT CONTROL UNION CANADA INC.
Control Union Canada Inc. is a member of the Peterson Control Union Group which has operations in 85+ countries. The group has more than 6 thousand employees that have audited commodities of all types for over 100 years. Peterson Control Union boasts many of the largest corporations in the world as their customers. They have significant history supporting and auditing commodities certifications and process standards for biofuels, sugar, palm oil, soy, and many other commodities. See https://www.petersoncontrolunion.com/en for references.
CONTACT INFORMATION
Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com
The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.
Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ goal of achieving industry leading profitability are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including the Company’s ability to meet international export standards, the potential for global expansion, and the Company's vision of becoming the global brand leader in premium and organic cannabis. These statements are based on current expectations, estimates, and projections about the Company’s business and the industry in which it operates. Risks and uncertainties associated with the forward-looking information in this press release include, among others, risks related to regulatory approvals, changes in market conditions, competition, supply chain disruptions, the Company's ability to maintain certification standards, and the successful implementation of its business strategy. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
FAQ
What certification did Rubicon Organics (ROMJF) receive in February 2025?
Which countries can Rubicon Organics (ROMJF) export cannabis to with the new certification?
When will Rubicon Organics (ROMJF) begin international exports?
What international standards does Rubicon Organics' (ROMJF) new certification comply with?
